Close Menu

CHICAGO (360Dx) – Data exists for hospitals to address the problems of sepsis and septic shock, but as with so many other areas of healthcare, that information has long been held in silos.

A four-year-old Israeli company named Clew Medical is trying to solve this dilemma by collecting data from multiple sources within hospitals, then applying machine learning and predictive analytics to catch potentially deadly events before they happen, allowing for earlier intervention and more appropriate treatment. The technology also has shown promise as way to rule out sepsis.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.